Order byBest matchMost fresh

Serena Williams on weight loss journey

Digest more
Serena Williams reveals she uses GLP-1 weight loss drug Zepbound: 'I just could never get back to where I needed to be’
Serena Williams is opening up about her fitness journey, revealing that she has lost 31 pounds using the injectable GLP-1 weight loss drug Zepbound, combined with consistent exercise and a healthy diet.

Continue reading

Serena Williams reveals GLP-1 weight loss in partnership with healthcare company Ro
Serena Williams Confirms She’s On Weight-Loss Drug After Fans Express Worry Over Her Looks
Serena Williams opens up on using weight loss medication: ‘I do everything but shortcuts'
Williams revealed that she began using GLP-1 receptor agonists, a class of drugs that includes Ozempic, Wegovy and Mounjaro, nearly a year ago.

Continue reading

Will Serena Williams's weight-loss admission help shed stigma of anti-obesity drugs?
Serena Williams flaunts her slimmed-down figure in a skimpy vest and shorts as she demonstrates how to use skinny jab in new ad - after revealing she dropped a whopping 31lbs thanks to the medication
Serena Williams loses 31 pounds with weight loss medication: How it transformed her wellness
The weight loss drug not only helped her slim down but also relieved her joint pain and improved her energy levels.

Continue reading

Serena Williams Reveals She Lost 14 kg Using Weight-Loss Medication: "I Feel Great"
Serena Williams adopts unique method of weight loss after struggling to get back in peak shape

Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those with previous adverse reactions.
PRIMETIMER on MSN1d

Serena Williams’ honest confession: Why she started taking Zepbound

Serena Williams opens up about hitting a weight loss plateau and why she turned to Zepbound to achieve her fitness goals.

Factbox-The race to launch first weight-loss pill

(Reuters) -Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ever-growing popularity of Eli Lilly's Zepbound and Novo Nordisk's Wegovy.
Baller Alert on MSN4d

Ozempic and Zepbound Lawsuits Explode: Patients Say Popular Weight-Loss Drugs Left Them Hospitalized

More than 2,000 lawsuits are now targeting the makers of Ozempic and Zepbound, with patients claiming the drugs caused dangerous and sometimes permanent health problems. The cases, consolidated in Pennsylvania
Feedback